Ocular manifestations of graft versus host disease

Current Opinion in Ophthalmology

Volumn 15, Issue 6, 2004, Pages 503-507

  Anderson, Nicholas G ^a   Regillo, Carl ^a  

^a WILLS EYE HOSPITAL   (United States)

Author keywords

Allogeneic stem cell transplantation; Bone marrow transplantation; Cornea; Graft versus host disease; Retina

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOSPORIN A; IMMUNOMODULATING AGENT; PREDNISOLONE ACETATE; RETINOIC ACID; TACROLIMUS;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CATARACT; CENTRAL SEROUS RETINOPATHY; CLINICAL FEATURE; CONJUNCTIVITIS; CORNEA PERFORATION; CORNEA ULCER; DERMATITIS; DISEASE ASSOCIATION; ECTROPION; EYE DISEASE; GRAFT VERSUS HOST REACTION; HUMAN; KERATOCONJUNCTIVITIS SICCA; LAGOPHTHALMOS; MEDICAL LITERATURE; MICROVASCULAR RETINOPATHY; POSTERIOR EYE CHAMBER; PRIORITY JOURNAL; PSEUDOMEMBRANOUS CONJUNCTIVITIS; RETINOPATHY; REVIEW; SYMPTOM; UVEITIS; VITILIGO;

ANTI-INFLAMMATORY AGENTS; BONE MARROW TRANSPLANTATION; EYE DISEASES; GRAFT VS HOST DISEASE; HUMANS; IMMUNOLOGIC FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 9444248144     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.icu.0000143684.22362.46     Document Type: Review

References (44)

1. Kerty E, et al.: Ocular findings in allogeneic stem cell transplantation without total body irradiation. Ophthalmology 1999, 106:1334-1338.
2. Ng JS, et al.: Ocular complications of pediatric bone marrow transplantation. Ophthalmology 1999, 106:160-164.
3. Tabbara IA, et al.: Allogeneic hematopoietic stem cell transplantation: complications and results. Arch Intern Med 2002, 162:1558-1566.
4. Moon SJ, Mieler WF: Retinal complications of bone marrow and solid organ transplantation. Curr Opin Ophthalmol 2003, 14:433-442. The retinal complications of bone marrow and solid organ transplantation are reviewed.
5. Lopez PF, et al.: Bone marrow transplant retinopathy. Am J Ophthalmol 1991, 112:635-646.
6. Billingham RE: The biology of gratt-versus-host reactions. Harvey Lect 1966, 62:21-78.
7. Vogelsang GB: How I treat chronic graft-versus-host disease. Blood 2001, 97:1196-1201.
8. Dean RM, Bishop MR: Graft-versus-host disease: emerging concepts in prevention and therapy. Curr Hematol Rep 2003, 2:287-294.
9. Mohty M, et al.: Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study. Blood 2002, 100:3128-3134.
10. Johnson DA, Jabs DA: The ocular manifestations of graft-versus-host disease. Int Ophthalmol Clin 1997, 37:119-133.
11. Ho VT, Soiffer RJ: The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood 2001, 98:3192-3204.
12. Bray LC, et al.: Ocular complications of bone marrow transplantation. Br J Ophthalmol 1991, 75:611-614.
13. Thomas E, et al.: Bone-marrow transplantation (first of two parts). N Engl J Med 1975, 292:832-843.
14. Franklin RM, et al.: Ocular manifestations of graft-vs-host disease. Ophthalmology 1983, 90:4-13.
15. Jack MK, et al.: Ocular manifestations of graft-v-host disease. Arch Ophthalmol 1983, 101:1080-1084.
16. Hirst LW, et al.: The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol 1983, 101:580-584.
17. Mencucci R, et al.: Ophthalmological aspects in allogenic bone marrow transplantation: Sjogren-like syndrome in graft-versus-host disease. Eur J Ophthalmol 1997, 7:13-18.
18. Claes K, Kestelyn P: Ocular manifestations of graft versus host disease following bone marrow transplantation. Bull Soc Belge Ophtalmol 2000, 277: 21-26.
19. Jabs DA, et al.: The eye in bone marrow transplantation. II. Histopathology. Arch Ophthalmol 1983, 101:585-590.
20. Ogawa Y, et al.: Periductal area as the primary site for T-cell activation in lacrimal gland chronic graft-versus-host disease. Invest Ophthalmol Vis Sci 2003, 44:1888-1896.
21. Ogawa Y, et al.: A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD. Invest Ophthalmol Vis Sci 2001, 42: 111-119.
22. Jabs DA, et al.: The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol 1989, 107:1343-1348.
23. Rocha EM, et al.: GVHD dry eyes treated with autologous serum tears. Bone Marrow Transplant 2000, 25:1101-1103.
24. Ogawa Y, et al.: Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant 2003, 31:579-583. Autologous serum eye drops are safe and effective for managing severe dry eye associated with chronic GVHD.
25. Murphy PT, et al.: Successful use of topical retinoic acid in severe dry eye due to chronic graft-versus-host disease. Bone Marrow Transplant 1996, 18: 641-642.
26. Ahmad SM, et al.: Successful treatment of acute ocular graft-versus-host disease with tacrolimus (FK506). Cornea 2002, 21:432-433.
27. Ogawa Y, et al.: Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids. Cornea 2001, 20:430-434.
28. Kiang E, et al.: The use of topical cyclosporin A in ocular graft-versus-host-disease. Bone Marrow Transplant 1998, 22:147-151.
29. Robinson MR, et al.: Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease. Bone Marrow Transplant 2004, 33:1031-1035. Topical corticosteroids are used to treat seven patients with refractory dry eye due to chronic GVHD.
30. Peris-Martinez C, et al.: Multilayer amniotic membrane transplantation in severe ocular graft versus host disease. Eur J Ophthalmol 2001, 11:183-186.
31. Heath JD, Acheson JF, Schulenburg WE: Penetrating keratoplasty in severe ocular graft versus host disease. Br J Ophthalmol 1993, 77:525-526.
32. Tichelli A, et al.: Cataract formation after bone marrow transplantation. Ann Intern Med 1993, 119:1175-1180.
33. Dunn JP, et al.: Bone marrow transplantation and cataract development. Arch Ophthalmol 1993, 111:1367-1373.
34. Suh DW, et al.: Ocular findings after bone marrow transplantation in a pediatric population. Ophthalmology 1999, 106:1564-1570.
35. Penn EA, Soong HK: Cataract surgery in allogeneic bone marrow transplant recipients with graft-versus-host diseased(1). J Cataract Refract Surg 2002, 28:417-420.
36. Coskuncan NM, et al.: The eye in bone marrow transplantation. VI. Retinal complications. Arch Ophthalmol 1994, 112:372-379.
37. Bernauer W, et al.: Microvasculopathy in the ocular fundus after bone marrow transplantation. Ann Intern Med 1991, 115:925-930.
38. Fawzi AA, Cunningham ET Jr: Central serous chorioretinopathy after bone marrow transplantation. Am J Ophthalmol 2001, 131:804-805.
39. Cheng LL, et al.: Graft-vs-host-disease-associated conjunctival chemosis and central serous chorioretinopathy after bone marrow transplant. Am J Ophthalmol 2002, 134:293-295.
40. Kim RY, et al.: Scleritis as the initial clinical manifestation of graft-versus-host disease after allogenic bone marrow transplantation. Am J Ophthalmol 2002, 133:843-845.
41. Strouthidis NG, et al.: Posterior segment complications of graft versus host disease after bone marrow transplantation. Br J Ophthalmol 2003, 87:1421-1423.
42. West RH, Szer J, Pedersen JS: Ocular surface and lacrimal disturbances in chronic graft-versus-host disease: the role of conjunctival biopsy. Aust N Z J Ophthalmol 1991, 19:187-191.
43. Hanada R, Ueoka Y: Obstruction of nasolacrimal ducts closely related to graft-versus-host disease after bone marrow transplantation. Bone Marrow Transplant 1989, 4:125-126.
44. Khawly JA, et al.: Retinopathy and optic neuropathy in bone marrow transplantation for breast cancer. Ophthalmology 1996, 103:87-95.